Effect of Valproic acid, a Histone Deacetylase Inhibitor, on the Expression of Pluripotency and Neural Crest Specific Marker Genes in Murine Multipotent Skin Precursor Cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Cells that have endogenous multipotent properties can be used as a starting source for the generation of induced pluripotent cells (iPSC). In addition, small molecules associated with epigenetic reprogramming are also widely used to enhance the multi- or pluripotency of such cells. Skinderived precursor cells (SKPs) are multipotent, sphereforming and embryonic neural crest-related precursor cells. These cells can be isolated from a juvenile or adult mammalian dermis. SKPs are also an efficient starting cell source for reprogramming and the generation of iPSCs because of the high expression levels of Sox2 and Klf4 in these cells as well as their endogenous multipotency. In this study, valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, was tested in the generation of iPSCs as a potential enhancer of the reprogramming potential of SKPs. SKPs were isolated from the back skins of 5-6 week old C57BL/6 X DBA/2 F1 mice. After passage 3, the SKPs was treated with 2 mM of VPA and the quantitative real time RT-PCR was performed to quantify the expression of Oct4 and Klf4 (pluripotency specific genes), and Snai2 and Ngfr (neural crest specific genes). The results show that Oct4 and Klf4 expression was decreased by VPA treatment. However, there were no significant changes in neural crest specific gene expression following VPA treatment. Hence, although VPA is one of the most potent of the HDAC inhibitors, it does not enhance the reprogramming of multipotent skin precursor cells in mice.
Abstract
Cells that have endogenous multipotent properties can be used as a starting source for the generation of induced pluripotent cells (iPSC). In addition, small molecules associated with epigenetic reprogramming are also widely used to enhance the multi- or pluripotency of such cells. Skinderived precursor cells (SKPs) are multipotent, sphereforming and embryonic neural crest-related precursor cells. These cells can be isolated from a juvenile or adult mammalian dermis. SKPs are also an efficient starting cell source for reprogramming and the generation of iPSCs because of the high expression levels of Sox2 and Klf4 in these cells as well as their endogenous multipotency. In this study, valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, was tested in the generation of iPSCs as a potential enhancer of the reprogramming potential of SKPs. SKPs were isolated from the back skins of 5-6 week old C57BL/6 X DBA/2 F1 mice. After passage 3, the SKPs was treated with 2 mM of VPA and the quantitative real time RT-PCR was performed to quantify the expression of Oct4 and Klf4 (pluripotency specific genes), and Snai2 and Ngfr (neural crest specific genes). The results show that Oct4 and Klf4 expression was decreased by VPA treatment. However, there were no significant changes in neural crest specific gene expression following VPA treatment. Hence, although VPA is one of the most potent of the HDAC inhibitors, it does not enhance the reprogramming of multipotent skin precursor cells in mice.
참고문헌 (36)
- Biernaskie J, "Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury", J Neurosci, 27, pp.9545~9559 (2007)
- Bug G, "Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells", Cancer Res, 65, pp.2537~2541 (2005)
- Buranasinsup S, "In vitro osteogenesis from human skin-derived precursor cells", Dev Growth Differ, 48, pp.263~269 (2006)
- Eminli S, "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells", Nat Genet, 41, pp.968~976 (2009)
- Fernandes KJ, "Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential", Philos Trans R Soc Lond B Biol Sci, 363, pp.185~198 (2008)
- Fernandes KJ, "Isolation, expansion, and differentiation of mouse skin-derived precursors", Methods Mol Biol, 482, pp.159~170 (2009)
- Hanna J, "Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency", Cell, 133, pp.250~264 (2008)
- Hsieh J, "Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells", Proc Natl Acad Sci U S A, 101, pp.16659~16664 (2004)
- Huangfu D, "Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds", Nat Biotechnol, 26, pp.795~797 (2008)
- Hunt DP, "Multipotent skin-derived precursors: from biology to clinical translation", Curr Opin Biotechnol, 20, pp.522~530 (2009)
- Jung GA, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip", WAF1 pathway, 2008, pp.9, 66~
- Kim JB, "Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors", Nature, 454, pp.646~650 (2008)
- Kim JB, "Direct reprogramming of human neural stem cells by OCT4", Nature, 461, pp.643~649 (2009)
- Kuendgen A, "The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia", Cancer, 106, pp.112~119 (2006)
- Li Y, "Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4", Blood, 105, pp.635~637 (2005)
- Loh YH, "Generation of induced pluripotent stem cells from human blood", Blood, 113, pp.5476~5479 (2009)
- McKenzie IA, "Skin derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system", J Neurosci, 26, pp.6651~6660 (2006)
- Nakagawa M, "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts", Nat Biotechnol, 26, pp.101~106 (2008)
- Nichols J, "Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4", Cell, 95, pp.379~391 (1998)
- Niwa H, "Quantitative expression of Oct-3", 4 defines differentiation, dedifferentiation or self-renewal of ES cells, 2000, pp.24, 372~376
- Okita K, "Generation of germline-competent induced pluripotent stem cells", Nature, 448, pp.313~317 (2007)
- Perucca E, "Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience", CNS Drugs, 16, pp.695~714 (2002)
- Phiel CJ, "Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen", J Biol Chem, 276, pp.36734~36741 (2001)
- Qiu Z, "Skeletal myogenic potential of mouse skin-derived precursors", Stem Cells Dev, 19, pp.259~268 (2010)
- Schuh R, "A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene", Cell, 47, pp.1025~1032 (1986)
- Shi Y, "A combined chemical and genetic approach for the generation of induced pluripotent stem cells", Cell Stem Cell, 2, pp.525~528 (2008)
- Sun N, "Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells", Proc Natl Acad Sci U S A, 106, pp.15720~15725 (2009)
- Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
- Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
- Teng HF, "Valproic acid enhances Oct4 promoter activity in myogenic cells", J Cell Biochem, 110, pp.995~1004 (2010)
- Toma JG, "Isolation of multipotent adult stem cells from the dermis of mammalian skin", Nat Cell Biol, 3, pp.778~784 (2001)
- Toma JG, "Isolation and characterization of multipotent skin-derived precursors from human skin", Stem Cells, 23, pp.727~737 (2005)
- Wernig M, "c-Myc is dispensable for direct reprogramming of mouse fibroblasts", Cell Stem Cell, 2, pp.10~12 (2008)
- Yu IT, "Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation", Neuropharmacology, 56, pp.473~480 (2009)
- Yu J, "Induced pluripotent stem cell lines derived from human somatic cells", Science, 318, pp.1917~1920 (2007)
- Zhang P, "Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression", J Biol Chem, 285, pp.9180~9189 (2010)
